Prioritization of cancer therapeutic targets using CRISPR–Cas9 screensFiona M. Behan, Mathew J. Garnett, Charlotte Beaver et al.|Nature|2019Cited by 1.4k
Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screeningGabriele Picco, Mathew J. Garnett, Elisabeth Chen et al.|Nature Communications|2019Cited by 134